Esophageal, Gastric & Duodenal Disorders

Dear Member of the Esophageal, Gastric & Duodenal Disorders Section and interested others:

Thank you for making our sessions at the 41st annual DDW® in New Orleans, LA a tremendous success! If you have specific feedback regarding speakers sponsored by the Esophageal, Gastric & Duodenal Disorders Section (EGD) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2011 in Chicago.

Highlights of EGD section's success include the fact that one of our section's abstracts, "Laparoscopic Antireflux Surgery vs Long-term Esomeprazole Treatment for Chronic GERD". Final Results After 5 yrs of Follow up in the LOTUS Study" was accepted for presentation at the highly successful AGA Institute Clinical Science Plenary Session. In addition, 22% of EGD accepted abstracts were selected for oral presentation while 28% were selected as oral presentations or posters of distinction!

This year's DDW was an exciting and scientifically robust meeting featuring the very best clinical, translational and basic research in Gastroenterology. We took into account the many suggestions sent by our membership and tried to incorporate as many as possible into planning the program. Some of the EGD program highlights included the following:

EGD Abstract Selection 2010
Total Abstracts submitted 661
Accepted Abstracts 512
Oral Presentations 111
Posters 401
Posters of Distinction 32

During DDW® 2010 EGD sponsored Clinical and Translational Symposia, and abstract based Research and Topic Fora.

EGD Session
Sunday, May 2, 20100 Attendance
Research Forum: Barrett's Esophagus and Esophageal Adenocarcinoma 8:30am-10:00am 200*
Research Forum: New insights into the epidemiology of H. pylori-induced diseases 10:30am- 12:00pm 75
Research Forum: Barrett's Esophagus: Surveillance and Treatment 10:30am- 12:00pm 590*
Research Forum: Clinical dilemmas in the treatment of Helicobacter pylori 2:15pm-3:45pm 100
Research Forum: Manipulation of host responses by H. pylori 4:00pm-5:30pm 70
Monday, May 3, 2010
Clinical Symposium: Unanswered Questions in Barrett's Esophagus 2:15pm-3:45pm 200*
Research Forum: Dyspepsia and GERD: clinical and physiological aspects 2:15pm-3:45pm 95
Research Forum: Novel mechanisms that regulate gastroduodenal secretion and defense 2:15pm-3:45pm 100
Esophageal, Gastric and Duodenal Disorders Distinguished Abstracts Plenary 4:00pm-5:30pm 200*
Esophageal, Gastric and Duodenal Disorders Section Business Meeting 5:30pm-6:30pm unknown
Tuesday, May 4, 2010
Research Symposium: Personalized Medicine and Gastroenterology 8:30am-10:00am 35
Research Forum: Gastroesophageal Reflux Disease: Diagnosis 8:30am-10:00am 200*
Topic Forum: Pathobiology of Gastroesophageal Carcinoma 8:30am-10:00am 45
Clinical Symposium: Treatment Options in Reflux Disease: The Good and the Bad 10:30am- 12:00pm 650*
Research Forum: Epithelial responses to H. pylori that promote carcinogenesis 10:30am- 12:00pm 100
Research Forum: Outcomes in Non-Variceal Upper GI Bleeding 10:30am- 12:00pm 125
Clinical Symposium: Helicobacter pylori: Friend or Foe? 2:15pm-3:45pm 400*
Research Forum: Risk factors and novel therapies for NSAID-induced injury 2:15pm-3:45pm 90
Topic Forum: Microbial factors that mediate H. pylori pathogenesis 4:00pm-5:30pm 60
Research Forum: Eosinophilic Esophagitis: From Basics to Clinical Care 4:00pm-5:30pm 170
Research Forum: Gastroesophageal Reflux Disease: Extra-esophageal Manifestations 4:00pm-5:30pm 230*
Wednesday, May 5, 2010
Clinical Symposium: Eosinophilic Esophagitis: Do We Know What We Are Doing? 8:30am-10:00am 300*
Research Forum: Mediators of gastroduodenal mucosal injury and restitution 8:30am-10:00am 45
Research Forum: Treatment of Gastroesophageal Reflux Disease 8:30am-10:00am 115
Research Forum: Barrett's Esophagus: Pathogenesis of metaplasia and dysplasia 8:30am-10:00am 35
Research Forum: Esophageal Motility Disorders: What's new in Achalasia 10:30am-12:00pm 200*
Research Forum: Gastroesophageal Reflux Disease: Pathogenesis 2:15pm-3:45pm 75

*highlighted sessions had an attendance of 200 or more

Each June, EGD section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute Sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (EGD descriptors may change as we plan for DDW 2011.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Esophageal, Gastric & Duodenal Disorders were shared at DDW.

Descriptor Name Abstracts Received Abstract Review Chair Associate Chair Abstract Reviewers
GERD: Pathogenesis 51 Jean-Paul Galmiche Jean-Paul Galmiche Richard Holloway, Roy Orlando, Peter Kahrilas
GERD: Diagnostic Testing 57 Joel Richter Jean-Paul Galmiche John Pandolfino, Jan Tack, Andre Smout
GERD: Complications and Extra-Esophageal Presentations 29 Marcelo Vela Michael Vaezi Ronnie Fass, Reza Shaker, Fabio Pace
GERD: Pharmacological Treatment 65 Radu Tutuian Michael Vaezi Peter Malfertheiner, Colin Howden, David Johnson
GERD: Non-Pharmacological Therapies (Surgical, Intraluminal, Alternative and Others) 15 Roy Wong Michael Vaezi Ravinder Mittal, John Vargo, Christopher Thompson
Barrett's Esophagus: Diagnosis and Management 32 Amitabh Chak Kenneth Wang Ajay Bansal, Lauren Gerson, Massimo Conio, Gary Falk
Barrett's Esophagus: Pathogenesis 35 Rebecca Fitzgerald Kenneth Wang Rhonda Souza, Joel Rubenstein, Robert Odze, Yvonne Romero
Barrett's-Related Esophageal Adenocarcinoma 24 Stuart Spechler Kenneth Wang Peter Siersema, Liam Murray, Douglas Corley
Clinical Acid-Peptic and Other Gastroduodenal Disorders 21 Gary Falk Nimish Vakil Ken DeVault, Richard Holloway, Roberto Penagini
Dyspepsia 16 Paul Moayyedi Nimish Vakil Hirota Miwa, Mel Wilcox
Eosinophilic Esophagitis and Gastroenteritis 45 Glenn Furuta Ikuo Hirano Nirmala Gonsalves, Simon Hogan, David Katzka
Non-Variceal UGI Bleeding 19 Uri Ladabaum Ikuo Hirano Louis Wong Kee Song, Laura Targownik
NSAIDs: Clinical Evaluation and Pathogenesis 8 Ernst Kuipers Jay Goldstein Angel Lanas, Peter Konturek, Sandor Szabo
NSAIDs: Treatment and Prevention of Complications 15 Byron Cryer Jay Goldstein John Wallace, Angel Lanas, Loren Laine
Gastroduodenal Secretion: Neural, Hormonal, Intracellular 14 Gordon Ohning Andrzej Tarnawski Ursula Seidler, Adam Smolka, Mitch Schubert
Mucosal Defense 11 Susan Hagen Andrzej Tarnawski Marc Basson, Nimish Vakil, Koji Takeuchi, Andre Dubois
Mucosal Injury, Repair and Healing 39 Jiang-Yang Wang Andrzej Tarnawski Nimish Vakil, Tetsuo Arakawa, James Goldenring, Jonathan Kaunitz
Helicobacter pylori: Epidemiology and Disease Associations 21 Francis Megraud Ben Gold Guillermo Perez-Perez, Naoki Chiba, Dulciene Queiroz
Helicobacter pylori: Diagnosis, Treatment and Antimicrobial Resistance 41 Lori Fischbach Ben Gold Dino Vaira, Colm O'Morain, Sibylle Koletzko
Helicobacter pylori: Pathogenesis: H. pylori-Induced Inflammation and Immune Response 17 Richard Ferrero Nicola Jones John Kao, Steve Czinn, Paul Harris
Helicobacter pylori: Pathogenesis: Bacterial and Environmental Factors 16 Sarah Keates Nicola Jones Yoshio Yamaoka, Andrew Day, Nina Salama
Helicobacter pylori: Pathogenesis: Gastric Epithelial Responses and Carcinogenesis 20 JeanMarie Houghton Nicola Jones Sheila Crowe, Emad El-Omar, Steven Moss
Dysmotility and other Non-Reflux Esophageal Disorders (Cross-section descriptor) 36 Daniel Sifrim Ikuo Hirano Benson Massey, Chandra Prakash Gyawali
Stem Cell Biology (Cross-section descriptor) 3 Michael Choi   Steve Cohn, Bart Rountree, Tim Wang, Courtney Houchen
Gastric Neoplasms: Precursors, Biology, Diagnosis and Therapy (Cross-section descriptor) 14 Juanita Merchant   Sheila Crowe, John Kao

Section leaders will review committee membership this summer for new abstract review committees to confirm the final composition for DDW 2011 committees.

EGD section members interested in serving in this capacity are strongly encouraged to contact us and volunteer to review abstracts. You can join the EGD section at any time.

We encourage you to submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW as well as recommendations for new abstract descriptors. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please forward your suggestions to John Whiton, AGA Institute by July 1, 2010.

Members interested in participating in the various activities of the Section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.

Thank you so much for your continuing strong support of the Esophageal, Gastric & Duodenal Disorders Section.

Sincerely,

Richard M. Peek Jr., MD, AGAF
Chair, EGD Section, AGA Institute Council

Prateek Sharma, MD
Vice-Chair, EGD Section, AGA Institute Council